High Court relief to Sun Pharma, Ahd Co barred from using 'Esiraft'

Sun Pharmaceutical Industries has received a significant legal victory. The Bombay High Court has stopped Meghmani Lifesciences from using its product mark 'Esiraft'. This decision comes after Sun Pharma alleged trademark infringement and passing off rights concerning its brand 'Raciraft'. The court found the marks visually and phonetically similar, likely to cause confusion among consumers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y7qcWhH
via IFTTT